Cleared Traditional

K032157 - TELEMIS-MEDICAL SOLUTION

K032157 is an FDA 510(k) clearance for TELEMIS-MEDICAL SOLUTION, manufactured by Telemis S.A.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 72-day FDA review.

K032157 · Telemis S.A. · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2003
Decision
72d
Days
Class 2
Risk

K032157 is an FDA 510(k) clearance for the TELEMIS-MEDICAL SOLUTION. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Telemis S.A. (Gaithersburg, US). The FDA issued a Cleared decision on September 24, 2003 after a review of 72 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K032157

510(k) Number K032157 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 2003
Decision Date September 24, 2003
Days to Decision 72 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 107d · This submission: 72d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2293
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K032157.
SECTRA ORTHOPEDIC PACKAGE
K031590 · Sectra-Imtec AB · Oct 2003
ECHOENCODER
K032324 · Icardiogram, Incorporated · Oct 2003
RATTAN IMACS BY RATTAN INFORMATION CORPORATION
K032176 · Rattan Information Corporation · Sep 2003
APAX PACS SYSTEM
K032760 · Tis, Inc. · Sep 2003
DOME CX DIGITAL FLAT-PANEL DISPLAY SYSTEM MODEL, C3 COLOR AND C3 GRAY
K032638 · Planar Systems, Inc. · Sep 2003
51CM(20.1INCH) TFT MONOCHROME LCD MONITOR, MU5111BW
K032020 · Iiyama Corporation · Sep 2003
K032157 · TELEMIS-MEDICAL SOLUTION
Download PDF FDA Summary Telemis S.A.